Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 40611 record(s)

Req # A-2019-001475

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-119737-837.

Organization: Health Canada

79 page(s)
March 2020

Req # A-2019-001484

Adverse Reaction Report (AER). Report numbers: E2B_02216112, 000717858, 000727615, E2B_00571140, E2B_00280120, 000685895, 000530577, E2B_01672103.

Organization: Health Canada

46 page(s)
March 2020

Req # A-2019-001501

Adverse Reaction Report (AER) for ONDANSETRON. Report numbers: E2B_02563606, E2B_02567480, E2B_02567680, E2B_02567753, E2B_02571395, E2B_02578682, E2B_02579659, E2B_02580616, E2B_02587235, E2B_02607214, E2B_02613380, E2B_02622326, E2B_02662711,…

Organization: Health Canada

364 page(s)
March 2020

Req # A-2019-001531

Adverse Reaction Report (AER). Report numbers: 000633112, E2B_00926876, E2B_02189164.

Organization: Health Canada

51 page(s)
March 2020

Req # A-2019-001542

Adverse Reaction Report (AER). Report numbers: 000725020, E2B_00267242, 000516682, E2B_01318165, E2B_01318148, E2B_01318135, 000712654, 000516348, 000516685, 000612254, 000613636, E2B_01768498.

Organization: Health Canada

68 page(s)
March 2020

Req # A-2019-001568

Adverse Reaction Report (AER). Report numbers: E2B_01317931, E2B_02592729, 000720712, E2B_01390001.

Organization: Health Canada

34 page(s)
March 2020

Req # A-2019-001596

Adverse Reaction Report (AER) for ENTYVIO. Report numbers: 000729452, 000729545, E2B_02736316, E2B_02736386, E2B_02747272.

Organization: Health Canada

61 page(s)
March 2020

Req # A-2019-001598

Adverse Reaction Report (AER) for NINLARO. Report number: E2B_02747790.

Organization: Health Canada

13 page(s)
March 2020

Req # A-2019-001602

Adverse Reaction Report (AER) for PANTOPRAZOLE. Report numbers: 000728933, 000729469, E2B_02721101, E2B_02726898, E2B_02727599, E2B_02733268, E2B_02738003, E2B_02742861, E2B_02743130, E2B_02745655, E2B_02747521, E2B_02747529, E2B_02751738,…

Organization: Health Canada

614 page(s)
March 2020

Req # A-2019-001619

Adverse Reaction Report (AER) for Cipralex® (escitalopram). Report numbers: E2B_02535962, E2B_02543869, 000726867, 000726987, 000727052, E2B_02585107 and E2B_02610804 AER for Celexa® (citalopram). Report numbers: 000724951, E2B_02528143,…

Organization: Health Canada

336 page(s)
March 2020
Date modified: